BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

222 related articles for article (PubMed ID: 15715685)

  • 1. Nt-proANP in plasma, a marker of salt sensitivity, is reduced in type 2 diabetes patients.
    Melander O; Frandsen E; Magnusson M; Grubb A; Jovinge S; Groop L
    J Intern Med; 2005 Mar; 257(3):281-8. PubMed ID: 15715685
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Risk assessment in patients with unstable angina/non-ST-elevation myocardial infarction and normal N-terminal pro-brain natriuretic peptide levels by N-terminal pro-atrial natriuretic peptide.
    Jarai R; Iordanova N; Jarai R; Raffetseder A; Woloszczuk W; Gyöngyösi M; Geyer G; Wojta J; Huber K
    Eur Heart J; 2005 Feb; 26(3):250-6. PubMed ID: 15618049
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Moderate salt restriction effectively lowers blood pressure and degree of salt sensitivity is related to baseline concentration of renin and N-terminal atrial natriuretic peptide in plasma.
    Melander O; von Wowern F; Frandsen E; Burri P; Willsteen G; Aurell M; Hulthén UL
    J Hypertens; 2007 Mar; 25(3):619-27. PubMed ID: 17278979
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Midregional pro-atrial natriuretic peptide is a useful indicator for the detection of impaired left ventricular function in patients with coronary artery disease.
    Elmas E; Brueckmann M; Lang S; Kälsch T; Haghi D; Sueselbeck T; Dempfle CE; Borggrefe M
    Int J Cardiol; 2008 Aug; 128(2):244-9. PubMed ID: 17673312
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparison of midregional pro-atrial natriuretic peptide with N-terminal pro-B-type natriuretic peptide in predicting survival in patients with chronic heart failure.
    von Haehling S; Jankowska EA; Morgenthaler NG; Vassanelli C; Zanolla L; Rozentryt P; Filippatos GS; Doehner W; Koehler F; Papassotiriou J; Kremastinos DT; Banasiak W; Struck J; Ponikowski P; Bergmann A; Anker SD
    J Am Coll Cardiol; 2007 Nov; 50(20):1973-80. PubMed ID: 17996563
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Increased plasma levels of NT-proANP and NT-proBNP as markers of cardiac dysfunction in septic patients.
    Hoffmann U; Brueckmann M; Bertsch T; Wiessner M; Liebetrau C; Lang S; Haase KK; Borggrefe M; Huhle G
    Clin Lab; 2005; 51(7-8):373-9. PubMed ID: 16122147
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Personal experience with determination of NT-proBNP in clinical practice].
    Stejskal D; Oral I; Lacnák B; Juráková R; Horalík D; Adamovská S; Prosková J; Hrabovská I; Ozanová G
    Vnitr Lek; 2003 Feb; 49(2):121-6. PubMed ID: 12728579
    [TBL] [Abstract][Full Text] [Related]  

  • 8. ProANP and NT-proBNP levels to prospectively assess cardiac function in breast cancer patients treated with cardiotoxic chemotherapy.
    Kouloubinis A; Kaklamanis L; Ziras N; Sofroniadou S; Makaritsis K; Adamopoulos S; Revela I; Athanasiou A; Mavroudis D; Georgoulias V
    Int J Cardiol; 2007 Nov; 122(3):195-201. PubMed ID: 17289172
    [TBL] [Abstract][Full Text] [Related]  

  • 9. NT-proBNP in normoalbuminuric patients with Type 2 diabetes mellitus.
    Andersen NH; Poulsen SH; Knudsen ST; Heickendorff L; Mogensen CE
    Diabet Med; 2005 Feb; 22(2):188-95. PubMed ID: 15660737
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Natriuretic peptides in patients with aortic stenosis.
    Qi W; Mathisen P; Kjekshus J; Simonsen S; Bjørnerheim R; Endresen K; Hall C
    Am Heart J; 2001 Oct; 142(4):725-32. PubMed ID: 11579366
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Plasma concentrations of natriuretic peptides in normal cats and normotensive and hypertensive cats with chronic kidney disease.
    Lalor SM; Connolly DJ; Elliott J; Syme HM
    J Vet Cardiol; 2009 May; 11 Suppl 1():S71-9. PubMed ID: 19398225
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Plasma N-terminal pro-brain natriuretic peptide: a marker of left ventricular hypertrophy in hypertrophic cardiomyopathy.
    Brito D; Matias JS; Sargento L; Cabral MJ; Madeira HC
    Rev Port Cardiol; 2004 Dec; 23(12):1557-82. PubMed ID: 15732658
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prognostic merit of N-terminal-proBNP and N-terminal-proANP in mechanically ventilated critically ill patients.
    Berdal JE; Stavem K; Omland T; Hall C; Smith-Erichssen N
    Acta Anaesthesiol Scand; 2008 Oct; 52(9):1265-72. PubMed ID: 18823467
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Natriuretic peptides and hemodynamics in preeclampsia.
    Tihtonen KM; Kööbi T; Vuolteenaho O; Huhtala HS; Uotila JT
    Am J Obstet Gynecol; 2007 Apr; 196(4):328.e1-7. PubMed ID: 17403408
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparison of midregional pro-atrial and B-type natriuretic peptides in chronic heart failure: influencing factors, detection of left ventricular systolic dysfunction, and prediction of death.
    Moertl D; Berger R; Struck J; Gleiss A; Hammer A; Morgenthaler NG; Bergmann A; Huelsmann M; Pacher R
    J Am Coll Cardiol; 2009 May; 53(19):1783-90. PubMed ID: 19422985
    [TBL] [Abstract][Full Text] [Related]  

  • 16. High plasma N-terminal pro-brain natriuretic peptide level found in diabetic patients after myocardial infarction is associated with an increased risk of in-hospital mortality and cardiogenic shock.
    Vergès B; Zeller M; Desgrès J; Dentan G; Laurent Y; Janin-Manificat L; L'Huillier I; Rioufol G; Beer JC; Makki H; Rochette L; Gambert P; Cottin Y
    Eur Heart J; 2005 Sep; 26(17):1734-41. PubMed ID: 15831555
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Plasma ProANP(1-30) reflects salt sensitivity in subjects with heredity for hypertension.
    Melander O; Frandsen E; Groop L; Hulthén UL
    Hypertension; 2002 May; 39(5):996-9. PubMed ID: 12019282
    [TBL] [Abstract][Full Text] [Related]  

  • 18. NT-proBNP, NT-proANP and cTnI concentrations in dogs with pre-capillary pulmonary hypertension.
    Kellihan HB; Mackie BA; Stepien RL
    J Vet Cardiol; 2011 Sep; 13(3):171-82. PubMed ID: 21835711
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Plasma N-terminal Pro-Brain Natriuretic Peptide (Nt-proBNP) level and prognosis after myocardial infarction in diabetes.
    Vergès B; Zeller M; Beer JC; Cottin Y;
    Diabetes Metab; 2008 Feb; 34 Suppl 1():S10-5. PubMed ID: 18358421
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Determinants of N-terminal proatrial natriuretic peptide plasma levels in a survey of adult male population from Southern Italy.
    Rubattu S; Barbato A; Marchitti S; Iacone R; Di Castro S; Evangelista A; Stanzione R; Ippolito R; Sciarretta S; Palmieri L; Volpe M; Strazzullo P;
    J Hypertens; 2010 Aug; 28(8):1638-45. PubMed ID: 20453667
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.